Kedra Wallace

Dr. Kedra Wallace

University of Mississippi Medical Center, Jackson, MS, USA
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2016 in Clinical Science
Verified
Journal Article
Closed access
PDF file
AHAshlyn C. Harmon
Ashlyn C. Harmon
DCDenise Creshun Cornelius
Denise Creshun Cornelius
LALorena M. Amaral
Lorena M. Amaral
JFJessica L. Faulkner
Jessica L. Faulkner
MCMark W. Cunningham
Mark W. Cunningham
BLBabbette LaMarca LaMarca
Babbette LaMarca LaMarca
Preeclampsia (PE) affects 5–7% of all pregnancies in the United States and is the leading cause of maternal and prenatal morbidity. PE is associated with hypertension after week 20 of gestation, decreased renal function and small-for-gestational-age babies. Women with PE exhibit chronic inflammation and production of autoantibodies. It is hypothesized that during PE, placental ischaemia occurs as a result of shallow trophoblast invasion which is associated with an immune imbalance where pro-inflammatory CD4+ T-cells are increased and T regulatory cells (Tregs) are decreased. This imbalance leads to chronic inflammation characterized by oxidative stress, pro-inflammatory cytokines and autoantibodies. Studies conducted in our laboratory have demonstrated the importance of this immune imbalance in causing hypertension in response to placental ischaemia in pregnant rats. These studies confirm that increased CD4+ T-cells and decreased Tregs during pregnancy leads to elevated inflammatory cytokines, endothelin (ET-1), reactive oxygen species (ROS) and agonistic autoantibodies to the angiotensin II (Ang II), type 1 receptor (AT1-AA). All of these factors taken together play an important role in increasing the blood pressure during pregnancy. Specifically, this review focuses on the decrease in Tregs, and their associated regulatory cytokine interleukin (IL)-10, which is seen in response to placental ischaemia during pregnancy. This study will also examine the effect of regulatory immune cell repopulation on the pathophysiology of PE. These studies show that restoring the balance of the immune system through increasing Tregs, either by adoptive transfer or by infusing IL-10, reduces the blood pressure and pathophysiology associated with placental ischaemia in pregnant rats.

1 August 2019 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
SASawsan As-Sanie
Sawsan As-Sanie
RBRebecca Black
Rebecca Black
LGLinda C. Giudice
Linda C. Giudice
TVTanika Gray Valbrun
Tanika Gray Valbrun
JGJhumka Gupta
Jhumka Gupta
RNRebecca A. Nebel
Rebecca A. Nebel

8 July 2017 in Current Hypertension Reports
Verified
Journal Article
Closed access
PDF file
LALorena M. Amaral
Lorena M. Amaral
Kedra WallaceKedra Wallace
Kedra Wallace
MOMichelle Owens
Michelle Owens
BLBabbette LaMarca LaMarca
Babbette LaMarca LaMarca

1 June 2013 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
JBJustin Brewer
Justin Brewer
MOMichelle Y. Owens
Michelle Y. Owens
Kedra WallaceKedra Wallace
Kedra Wallace
ARAmanda A. Reeves
Amanda A. Reeves
RMRachael Morris
Rachael Morris
JMJames N. Martin
James N. Martin

1 August 2010 in American Journal of Hypertension
Verified
Journal Article
Open access
PDF file
MPMarc R. Parrish
Marc R. Parrish
SMSydney R. Murphy
Sydney R. Murphy
SRSarah Rutland
Sarah Rutland
Kedra WallaceKedra Wallace
Kedra Wallace
KWKatrin Wenzel
Katrin Wenzel
BLBabbette LaMarca
Babbette LaMarca
Background. Preeclampsia is considered a disease of immunological origin associated with abnormalities in inflammatory cytokines, tumor necrosis factor

15 August 2012 in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
Verified
Journal Article
Closed access
PDF file
PDPushpinder Dhillion
Pushpinder Dhillion
Kedra WallaceKedra Wallace
Kedra Wallace
FHFlorian Herse
Florian Herse
JSJeremy Scott
Jeremy Scott
GWGerd Wallukat
Gerd Wallukat
BLBabbette LaMarca LaMarca
Babbette LaMarca LaMarca
Preeclampsia is associated with autoimmune cells TH17, secreting interleukin-17, autoantibodies activating the angiotensin II type I receptor (AT1-AA), and placental oxidative stress (ROS). The objective of our study was to determine whether chronic IL-17 increases blood pressure by stimulating ROS and AT1-AAs during pregnancy. To answer this question four groups of rats were examined: normal pregnant (NP, n = 20), NP+IL-17 ( n = 12), NP+tempol (4-hydroxy-2,2,6,6-tetramethylpiperidine- N-oxyl) ( n = 7) (a superoxide dismutase mimetic that scavenges ROS), and NP+IL-17+tempol ( n = 11). IL-17 (150 pg/day) was infused into NP rats while tempol was administered via the drinking water ad libitum. On day 19 blood pressure (MAP) was recorded, and plasma, urine, and tissue were collected for isolation of ROS detected by chemilluminescent technique. Urinary isoprostane was measured by ELISA. AT1-AAs were determined via cardiomyocyte assay and expressed as beats per minute. MAP increased from 98 ± 3 mmHg in NP to 123 ± 3 mmHg in IL-17-infused NP rats. Urinary isoprostane increased from 1,029 ± 1 in NP to 3,526 ± 2 pg·mg−1·day−1 in IL-17-infused rats ( P < 0.05). Placental ROS was 436 ± 4 RLU·ml−1·min−1 ( n = 4) in NP and 702 ± 5 ( n = 5) RLU·ml−1·min−1 in IL-17-treated rats. Importantly, AT1-AA increased from 0.41 ± 0.05 beats/min in NP rats ( n = 8) to 18.4 ± 1 beats/min in IL-17 rats ( n = 12). Administration of tempol attenuated the hypertension (101 ± 3 mmHg) ROS (459 ± 5 RLU·ml−1·min−1) and blunted AT1-AAs (7.3 ± 0.6 beats/min) in NP+IL-17+tempol-treated rats. Additionally, AT1 receptor blockade inhibited IL-17-induced hypertension and placental oxidative stress. MAP was 105 ± 5 mmHg and ROS was 418 ± 5 RLU·ml−1·min−1 in NP+IL 17-treated with losartan. These data indicate that IL-17 causes placental oxidative stress, which serves as stimulus modulating AT1-AAs that may play an important role in mediating IL-17-induced hypertension during pregnancy.